Old Web
English
Sign In
Acemap
>
authorDetail
>
Annemarie M. Leliveld-Kors
Annemarie M. Leliveld-Kors
University Medical Center Groningen
Medicine
Radiology
89Zr-bevacizumab
Everolimus
Biomarker (medicine)
4
Papers
48
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour
2019
Cancers
Paranita Ferronika
Joost Hof
Gursah Kats-Ugurlu
Rolf H. Sijmons
Martijn Terpstra
Kim de Lange
Annemarie M. Leliveld-Kors
Helga Westers
Klaas Kok
Show All
Source
Cite
Save
Citations (11)
89Zr-bevacizumab PET : Potential Early Read Out for Efficacy of Everolimus in Metastatic Renal Cell Carcinoma Patients
2017
The Journal of Nuclear Medicine
Suzanne van Es
Adrienne H. Brouwers
Shekar V. K. Mahesh
Annemarie M. Leliveld-Kors
Igle J. de Jong
Marjolijn N. Lub-de Hooge
Elisabeth G.E. de Vries
Jourik A. Gietema
Sjoukje F. Oosting
Show All
Source
Cite
Save
Citations (4)
89Zr-bevacizumab PET
2017
The Journal of Nuclear Medicine
van Suzanne Es
Adrienne H. Brouwers
Shekar V. K. Mahesh
Annemarie M. Leliveld-Kors
de Igle Jan Jong
Marjolijn N. Lub-de Hooge
de Elisabeth G. E. Vries
Jourik A. Gietema
Sjoukje F. Oosting
Show All
Source
Cite
Save
Citations (0)
89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma
2017
The Journal of Nuclear Medicine
Suzanne van Es
Adrienne H. Brouwers
Shekar V. K. Mahesh
Annemarie M. Leliveld-Kors
Igle J. de Jong
Marjolijn N. Lub-de Hooge
Elizabeth G.E. de Vries
Jourik A. Gietema
Sjoukje F. Oosting
Show All
Source
Cite
Save
Citations (33)
1